Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
企業コードFMS
会社名Fresenius Medical Care AG
上場日Oct 02, 1996
設立日2006
最高経営責任者「CEO」Dr. Katarzyna Mazur-Hofsaess
従業員数111513
証券種類Ordinary Share
決算期末Oct 02
本社所在地Else-Kroener-Strasse 1
都市BAD HOMBURG VOR DER HOHE
証券取引所TSX Venture Exchange (former Canadian Ventures Exchange)
国Germany
郵便番号61352
電話番号4961726090
ウェブサイトhttps://www.freseniusmedicalcare.com/
企業コードFMS
上場日Oct 02, 1996
設立日2006
過去5年間の配当金総支払額は
1.94B
米ドルである。
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020